NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only

NSABP Foundation, Inc.

General NSABP Information
  Financial Conflicts of
     Interest Policy
  Coalition Comment:
  IOM Report Group Comment
  Contact the NSABP
  Pathology Section
  Future Meetings
  NSABP Newsletters
  Media Info on STAR

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-51
  Protocol B-52
  Protocol B-53/S1207
  Protocol B-55/BIG 6-13

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR
  Protocol P-5

Scientific Publications

Related Web Sites

Medical Search Engines

To report problems, ask
questions or make comments,
please send e-mail to:

NSABP Clinical Trials Overview

Protocol R-03
A Clinical Trial to Evaluate the Worth of Preoperative Multimodality Therapy (5FU+LV+RTX) in Patients with Operable Carcinoma of the Rectum

Specific Aims
The primary purpose of this study is to determine whether the administration of preoperative chemotherapy (5FU+LV) and radiotherapy, followed by postoperative chemotherapy, is more effective than the administration of postoperative chemotherapy and radiotherapy in improving the disease-free survival and survival of patients with operable carcinoma of the rectum. Secondary aims of the study include the assessment of the effect of preoperative therapy on tumor response, tumor downstaging, rate of local recurrence, and type of operation (sphincter-saving procedures versus abdominoperineal resections).